News
TXG
10.76
+4.06%
0.42
Weekly Report: what happened at TXG last week (0310-0314)?
Weekly Report · 18h ago
Stock selloff slashes needed-market cap for new Russell 2000 additions: Stephens
Seeking Alpha · 4d ago
2 Reasons to Sell TXG and 1 Stock to Buy Instead
Barchart · 6d ago
Weekly Report: what happened at TXG last week (0303-0307)?
Weekly Report · 03/10 09:22
Insider Sale: Chief Executive Officer of $TXG Sells 7,942 Shares
NASDAQ · 03/05 00:05
10x Genomics Is Maintained at Buy by Citigroup
Dow Jones · 03/04 17:46
10x Genomics Price Target Cut to $15.00/Share From $20.00 by Citigroup
Dow Jones · 03/04 17:46
Citigroup Maintains Buy on 10x Genomics, Lowers Price Target to $15
Benzinga · 03/04 17:36
10X GENOMICS INC <TXG.O>: CITIGROUP CUTS TARGET PRICE TO $15 FROM $20
Reuters · 03/04 11:22
10x Genomics price target lowered to $15 from $20 at Citi
TipRanks · 03/04 10:36
U.S. RESEARCH ROUNDUP-California Resources, Eli Lilly, Mastec
Reuters · 03/04 07:27
10x Genomics gets injunction against Parse Biosciences' ATAC Products
Seeking Alpha · 03/03 21:43
10X GENOMICS: CO'S LITIGATION AGAINST PARSE'S GENE EXPRESSION PRODUCTS REMAINS ONGOING
Reuters · 03/03 21:11
10x Genomics Announces Consent Agreement: Parse Biosciences Agrees to Worldwide Permanent Injunction On ATAC Products, Admits Infringement Of 10x ATAC-Seq Patents
Benzinga · 03/03 21:09
Weekly Report: what happened at TXG last week (0224-0228)?
Weekly Report · 03/03 09:23
1 Stock Under $50 on Our Watchlist and 2 to Ignore
Barchart · 03/03 08:00
Director of 10x Genomics Picks Up 184% More Stock
Simply Wall St · 02/27 11:01
Weekly Report: what happened at TXG last week (0217-0221)?
Weekly Report · 02/24 09:23
Reported Sunday, 10x Genomics Unveils New Roadmap At AGBT, Boosting Tools For Mega-Scale Single Cell And Spatial Analysis
Benzinga · 02/24 07:28
10x Genomics unveils roadmap at AGBT general meeting
TipRanks · 02/23 20:45
More
Webull provides a variety of real-time TXG stock news. You can receive the latest news about 10X Genomics, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About TXG
More
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.